Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

111.17
-0.4966-0.44%
Post-market: 111.170.00000.00%19:30 EDT
Volume:141.85K
Turnover:15.75M
Market Cap:1.00B
PE:90.08
High:111.66
Open:111.56
Low:110.63
Close:111.67
52wk High:118.00
52wk Low:85.91
Shares:9.04M
Float Shares:9.04M
Volume Ratio:0.80
T/O Rate:1.57%
Dividend:2.18
Dividend Rate:1.96%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):143.17

Loading ...

Retension Pharmaceuticals, TRex Bio File for US IPO as Biotech Momentum Continues

Reuters
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Eli Lilly reports full FDA approval of Inluriyo combo for certain breast cancers

TIPRANKS
·
Yesterday

US FDA Approves Lilly Inluriyo-Verzenio Combo for ESR1-Mutated Metastatic Breast Cancer

Reuters
·
Yesterday

U.S. FDA Approves Inluriyo (Imlunestrant) in Combination with Verzenio (Abemaciclib) for Adults with Er+, Her2-, Esr1-Mutated Advanced or Metastatic Breast Cancer

THOMSON REUTERS
·
Yesterday

Eli Lilly - Inluriyo with Verzenio NOW Available in the United States

THOMSON REUTERS
·
Yesterday

Novo Nordisk’s Once-Weekly Insulin Study Signals a New Phase for Diabetes Care

TIPRANKS
·
Yesterday

Novartis AG Falls Friday, Outperforms Market

Dow Jones
·
Yesterday

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Yesterday

Novartis announces positive CHMP opinion for Cosentyx

TIPRANKS
·
Sep 18

AbbVie presents new Vraylar data at Psych Congress 2026

TIPRANKS
·
Sep 18

AbbVie Says Real-World Studies Show Vraylar Improves Symptoms in MDD, Bipolar I Depression

Reuters
·
Sep 18

Novo Nordisk's Sogroya Gets Positive EU Opinion for Children With Idiopathic Short Stature

MT Newswires Live
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Sep 18

Merck Says EU CHMP Backs Keytruda-Padcev Perioperative Use in Resectable Muscle-Invasive Bladder Cancer

Reuters
·
Sep 18

Merck & Co - Final Ec Decision Expected by Q4 2026

THOMSON REUTERS
·
Sep 18

Merck Receives Positive EU Chmp Opinion for Keytruda® (Pembrolizumab) Plus Padcev® (Enfortumab Vedotin-Ejfv) as Perioperative Treatment for Adults with Resectable Muscle-Invasive Bladder Cancer (Mibc)

THOMSON REUTERS
·
Sep 18

Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living with Hiv

THOMSON REUTERS
·
Sep 18

All 50 States Sign up for Trump's Medicaid Most-Favored-Nation Plan

Reuters
·
Sep 18

Sandoz Faces Uncertain Opportunity with New Drug Approval in Canada

Dow Jones
·
Sep 18